Arcus Biosciences (RCUS) Short-term Investments (2017 - 2026)
Arcus Biosciences (RCUS) recorded Short-term Investments of $552 million in Q2 2026, down 16.7% from $663 million a year earlier and down 11.1% from the prior quarter.
Powered by 
Analysis
Arcus Biosciences (RCUS) Short-term Investments (2017 - 2026) Analysis & Trends
At the end of FY2025, Arcus Biosciences reported Short-term Investments of $759 million, down 8.3% from FY2024.
- Annual Short-term Investments has a five-year compound annual growth rate of 6.5% (FY2020 to FY2025).
- Across earlier years, Short-term Investments came in at $828 million in FY2024 (+31.0%), $632 million in FY2023 (-21.3%), $803 million in FY2022 (+128.8%) and $351 million in FY2021 (-36.8%).
- The Q2 2026 figure is the lowest quarterly Short-term Investments since Q4 2021.
- On a year-over-year basis, Short-term Investments has declined for six consecutive quarters, with an average decline of 3.1% over the last eight quarters.
- Peak year-over-year performance for Short-term Investments in the last five years was growth of 140.8% in Q3 2022, against a decline of 38.4% in Q3 2021 at the low end.
- Per Business Quant, the preceding three quarters came in at $621 million (Q1 2026), $759 million (Q4 2025) and $593 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,261.99 Bn | 1,235.61 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 678.93 Bn | 598.79 Bn | 17.30 Bn |
| 3 | AbbVie | 518.29 Bn | 486.30 Bn | 13.12 Bn |
| 4 | Merck | 365.98 Bn | 328.92 Bn | 13.19 Bn |
| 5 | Novartis Ag | 316.85 Bn | 290.09 Bn | - |
| 6 | Astrazeneca | 293.40 Bn | 267.29 Bn | 13.26 Bn |
| 7 | Amgen | 251.78 Bn | 203.43 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 210.61 Bn | 185.71 Bn | 6.73 Bn |
| 9 | Pfizer | 166.87 Bn | 114.23 Bn | 12.56 Bn |
| 10 | Arcus Biosciences | 2.42 Bn | -713.13 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 479.00 Mn |
| Jun 30, 2026 | 552.00 Mn |
| Mar 31, 2026 | 621.00 Mn |
| Dec 31, 2025 | 759.00 Mn |
| Sep 30, 2025 | 593.00 Mn |
| Jun 30, 2025 | 663.00 Mn |
| Mar 31, 2025 | 805.00 Mn |
| Dec 31, 2024 | 828.00 Mn |
| Sep 30, 2024 | 888.00 Mn |
| Jun 30, 2024 | 813.00 Mn |
| Mar 31, 2024 | 810.00 Mn |
| Dec 31, 2023 | 632.00 Mn |
| Sep 30, 2023 | 615.00 Mn |
| Jun 30, 2023 | 700.00 Mn |
| Mar 31, 2023 | 716.00 Mn |
| Dec 31, 2022 | 803.00 Mn |
| Sep 30, 2022 | 831.14 Mn |
| Jun 30, 2022 | 900.15 Mn |
| Mar 31, 2022 | 664.75 Mn |
| Dec 31, 2021 | 351.00 Mn |
API Access
Arcus Biosciences Short-term Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=short-term-investments&ticker=RCUS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "short-term-investments", "ticker": "RCUS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=short-term-investments&ticker=RCUS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();